×
Breaking News
TIF WEBINAR SERIES 2026 | Bridging the Communication Gap in Haemoglobinopathy Care
WORLD BLOOD DONOR DAY 2026 | One Drop of Humanity. Give Blood. Save Lives.
EU APPROVES MITAPIVAT | A New Treatment Milestone for Adults with α- or β-Thalassaemia
NEW WHO GUIDELINES | Strengthening Global Guidance for Paediatric and Adolescent Sickle Cell Disease Care
TIF STATEMENT | A Plea for the Untold Victims of Conflict
APLASTIC ANAEMIA | ASH Publishes Guidelines on Diagnosis and Management of Severe and Very Severe Disease
INTERNATIONAL THALASSAEMIA DAY 2026 | First Campaign Materials Now Available
wAIHA | Rilzabrutinib Receives FDA Breakthrough Therapy Designation
INTERNATIONAL THALASSAEMIA DAY 2026 | A New Theme for Global Action
RARE DISEASE DAY 2026 | More Than You Can Imagine
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Other Anaemias
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Catherine Skari
Catherine Skari
Aug
- 2023 -
21 August
Tebapivat
Read More »
21 August
LYFGENIA™ (gene therapy)
Read More »
21 August
Oral Ferroportin Inhibitor
Read More »
21 August
CASGEVY™ (gene editing)
Read More »
21 August
Etavopivat
Read More »
21 August
PYRUKYND®
Read More »
21 August
Adakveo®
Read More »
21 August
Oxbryta®
Read More »
21 August
INTERCEPT™(pathogen inactivation)
Read More »
20 August
Hemanext ONE®
Read More »
Previous page
Next page
Back to top button
Close
Search for
